-
Australia's first locally made COVID-19 mRNA vaccine candidate is set for clinical trials
firstwordpharma
June 21, 2021
Victoria's acting premier James Merlino announced on Sunday his government had allocated AUD 5 million from a AUD 50 million mRNA research fund to help the Monash Institute of Pharmaceutical Sciences manufacture doses of its mRNA vaccine candidate for tri
-
Ascendo developing solution to rapid virus mutations
firstwordpharma
June 21, 2021
Ascendo has developed a proprietary NanoCherub electric-kinetic nanocomplex antigen adjuvant and delivery platform for a COVID-19 vaccine, as reported Taipei Times.
-
New Scamadviser Survey Find 28% of Consumers Would Consider Buying a Coronavirus Vaccine Online
prnewswire
June 21, 2021
Every year, Scamadviser analyzes the willingness of consumers to buy fake and counterfeit products online.
-
Risk of Covid plummets 21 days after first vaccine dose, analysis suggests
firstwordpharma
June 18, 2021
A new analysis suggests that the chance of getting COVID-19 after being vaccinated drops sharply 21 days following a first dose, as reported in This is Money.
-
Pfizer, Moderna Vaccines Do No Harm to Male Fertility: Study
drugs
June 18, 2021
The Pfizer and Moderna COVID vaccines pose no threat to male fertility, a finding experts hope will prompt more men to get vaccinated.
-
U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster Shots
drugs
June 18, 2021
An additional 200 million doses of the Moderna COVID-19 vaccine will be obtained by the U.S. government in case there is a need for booster shots.
-
EU drug regulator records 415 cases of possible rare blood clotting
firstwordpharma
June 18, 2021
The EU drug regulator said on Thursday it has received reports of 415 possible cases of thrombosis with thrombocytopenia syndrome in the EEA, out of over 50 million people who have gotten AstraZeneca and Johnson & Johnson's COVID-19 vaccines?.
-
Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-allotment Option for Gross Proceeds of $14.4 Million
firstwordpharma
June 18, 2021
Alzamend Neuro, today announced the closing of its initial public offering of 2,500,000 shares of its common stock and full exercise of the underwriter's over-allotment option to purchase 375,000 additional shares of common stock at a price to the public
-
Ahead of Tokyo Olympics, Japan Eases COVID-19 Restrictions
drugs
June 18, 2021
A coronavirus state of emergency in Tokyo and six other areas will be downgraded when it expires on Sunday as new daily cases continue to decline, the Japanese government said Thursday.
-
CureVac's COVID-19 Vaccine Only 47 Percent Effective
drugs
June 18, 2021
CureVac's COVID-19 vaccine was only 47 percent effective in a clinical trial, according to preliminary results released Wednesday that suggest the vaccine may not help fill the worldwide need for vaccines.